longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Global X S&P 500 U.S. Mkt Ldr TOP 50 ETF

FLAG

----
Start trading
OverviewOverviewNewsNewsPostsPostsWikiWikiRatingsRatingsCompositionCompositionDividendsDividends
LongbridgeAI
  • Weekly Recap | Unitedhealth -0.58%, consensus target above spot

    Weekly Review·Sep 19 at 07:02 AM
    UNH-1.22%UNHU-2.24%
  • Weekly Recap | Microsoft -0.37%, consensus target above spot

    Weekly Review·Sep 19 at 06:31 AM
    - Microsoft's stock price dropped by 0.37 % over the week to close at 493.78 USD, slightly underperforming the S&P 500 amid AI copyright disputes and ongoing business partnerships. - Fifty-five institutions maintained a strong buy consensus rating with a target price of approximately 572.92 USD, indicating about 16.0 % upside potential despite valuation disagreements. - Market participants will monitor upcoming macroeconomic data releases and developments regarding AI capital expenditure returns to gauge future stock momentum.
    MSFT-0.72%MSFD+0.73%
  • Weekly Recap | Merck +2.04%, most brokers rate it buy

    Weekly Review·Sep 19 at 06:23 AM
    MRK+0.94%
  • Weekly Recap | Home Depot -2.84%, most brokers rate it buy

    Weekly Review·Sep 19 at 06:07 AM
    HD+2.74%
  • Weekly Recap | Amazon -1.2%, data-centre deals stack up

    Weekly Review·Sep 19 at 05:34 AM
    - Amazon shares fell 1.2% to close at $253.71 this week, underperforming the S&P 500 index which dropped 0.08%. - The company advanced multiple data center and AI infrastructure partnerships, including deals with Generac, PPC, and Garmin, alongside regulatory scrutiny from the FTC and EU. - Institutional sentiment remained strong with a consensus rating of strong buy and an average target price of $328.22.
    AMZN-1.34%
  • Weekly Recap | Abbvie +2.66%, closing in on record highs

    Weekly Review·Sep 19 at 05:30 AM
    ABBV+0.28%
  • Weekly Recap | Abbvie +0.26%, most brokers rate it buy

    Weekly Review·Sep 12 at 07:40 AM
    ABBV+0.28%
  • Weekly Recap | Merck -4.26%, most brokers rate it buy

    Weekly Review·Sep 12 at 06:21 AM
    MRK+0.94%
  • Weekly Recap | Merck +1.33%, most brokers rate it buy

    Weekly Review·Sep 5 at 07:25 AM
    MRK+0.94%
  • Weekly Recap | Abbvie +0.38%, positive Phase 3 myeloma data

    Weekly Review·Sep 5 at 06:00 AM
    ABBV+0.28%
  • Weekly Recap | Merck -2.75%, closing in on record highs

    Weekly Review·Aug 29 at 06:04 AM
    MRK+0.94%
  • Weekly Recap | Abbvie -3.58%, most brokers rate it buy

    Weekly Review·Aug 29 at 05:11 AM
    ABBV+0.28%
  • Weekly Recap | Abbvie +6.21%, closing in on record highs

    Weekly Review·Aug 22 at 06:53 AM
    ABBV+0.28%
  • Weekly Recap | Merck +12.3%, closing in on record highs

    Weekly Review·Aug 22 at 05:28 AM
    MRK+0.94%